Molecular characterization of interleukin-4 and interleukin-6 in patients with type-2 diabetes mellitus in Iraq

Molecular characterization of interleukin-4 and interleukin-6 in patients with type-2 diabetes mellitus in Iraq

<p>This study aimed to investigate the association of polymorphisms of Interleukin-4 (IL-</p><p>4) and Interleukin-6 (IL-6) genes to the susceptibility and severity of type-2 diabetes</p><p>mellitus (T2DM) and to evaluate the seru...

Full description

Saved in:
Bibliographic Details
Main Author: Thamer, Dalfi Mazin Maky
Format: thesis
Language:eng
Published: 2021
Subjects:
QH Natural history
Online Access:https://ir.upsi.edu.my/detailsg.php?det=7334
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:ir.upsi.edu.my:7334
record_format uketd_dc
institution Universiti Pendidikan Sultan Idris
collection UPSI Digital Repository
language eng
topic QH Natural history
spellingShingle QH Natural history
Thamer, Dalfi Mazin Maky
Molecular characterization of interleukin-4 and interleukin-6 in patients with type-2 diabetes mellitus in Iraq
description <p>This study aimed to investigate the association of polymorphisms of Interleukin-4 (IL-</p><p>4) and Interleukin-6 (IL-6) genes to the susceptibility and severity of type-2 diabetes</p><p>mellitus (T2DM) and to evaluate the serum levels of these interleukins in patients with</p><p>T2DM. A number of 90 individuals from Wasit province, Iraq inclusive of 64 patients</p><p>with T2DM and 26 healthy individuals with normal fasting blood sugar as a control</p><p>group. Enzyme-linked immunosorbent assay (ELISA) was used to measure the levels</p><p>of IL-4 and IL-6 in sera from patients with T2DM. The allele-specific polymerase chain</p><p>reaction (PCR) technique was used to investigate the polymorphism of the interleukins:</p><p>IL4 -590C/T, (rs2243250) and IL6 -174G/C, (rs1800795) genes polymorphisms.</p><p>Results of this study showed that IL-4 concentrations had a non-significant difference</p><p>(p = >0.052) between patients with T2DM (154.48 pg/ml 7.00) with the control group</p><p>(151.49 pg/ml 6.21). Patients with T2DM revealed an elevated serum level of IL-6</p><p>(637.1 pg/ml 355.9) compared to control group (266.3 pg/ml 128.8). IL4 590 C/T</p><p>displayed that C allele is a major allele in the studied group. The CC genotype has an</p><p>association with T2DM and this genotype increases the probability of contracting the</p><p>T2DM with an odds ratio (OR) = 1.2222. The genetic polymorphism of IL6 174G/C</p><p>patients with T2DM showed a significant frequency (chi-square = 0.601, p = 0.001) of</p><p>IL-6 G/C genotype (31.25%) in comparison with controls (23%). IL6 174G/C</p><p>displayed that G allele is a major allele in the studied group. As a conclusion, the levels</p><p>of IL-4 may not be associated with T2DM, whereas, the elevated levels of IL-6 may be</p><p>related with T2DM. The study implicates that functional gene polymorphisms of IL-4</p><p>and IL-6 will provide additional information related to the pathogenesis of diabetes</p><p>mellitus.</p>
format thesis
qualification_name
qualification_level Master's degree
author Thamer, Dalfi Mazin Maky
author_facet Thamer, Dalfi Mazin Maky
author_sort Thamer, Dalfi Mazin Maky
title Molecular characterization of interleukin-4 and interleukin-6 in patients with type-2 diabetes mellitus in Iraq
title_short Molecular characterization of interleukin-4 and interleukin-6 in patients with type-2 diabetes mellitus in Iraq
title_full Molecular characterization of interleukin-4 and interleukin-6 in patients with type-2 diabetes mellitus in Iraq
title_fullStr Molecular characterization of interleukin-4 and interleukin-6 in patients with type-2 diabetes mellitus in Iraq
title_full_unstemmed Molecular characterization of interleukin-4 and interleukin-6 in patients with type-2 diabetes mellitus in Iraq
title_sort molecular characterization of interleukin-4 and interleukin-6 in patients with type-2 diabetes mellitus in iraq
granting_institution Universiti Pendidikan Sultan Idris
granting_department Fakulti Sains dan Matematik
publishDate 2021
url https://ir.upsi.edu.my/detailsg.php?det=7334
_version_ 1747833382708969472
spelling oai:ir.upsi.edu.my:73342022-08-22 Molecular characterization of interleukin-4 and interleukin-6 in patients with type-2 diabetes mellitus in Iraq 2021 Thamer, Dalfi Mazin Maky QH Natural history <p>This study aimed to investigate the association of polymorphisms of Interleukin-4 (IL-</p><p>4) and Interleukin-6 (IL-6) genes to the susceptibility and severity of type-2 diabetes</p><p>mellitus (T2DM) and to evaluate the serum levels of these interleukins in patients with</p><p>T2DM. A number of 90 individuals from Wasit province, Iraq inclusive of 64 patients</p><p>with T2DM and 26 healthy individuals with normal fasting blood sugar as a control</p><p>group. Enzyme-linked immunosorbent assay (ELISA) was used to measure the levels</p><p>of IL-4 and IL-6 in sera from patients with T2DM. The allele-specific polymerase chain</p><p>reaction (PCR) technique was used to investigate the polymorphism of the interleukins:</p><p>IL4 -590C/T, (rs2243250) and IL6 -174G/C, (rs1800795) genes polymorphisms.</p><p>Results of this study showed that IL-4 concentrations had a non-significant difference</p><p>(p = >0.052) between patients with T2DM (154.48 pg/ml 7.00) with the control group</p><p>(151.49 pg/ml 6.21). Patients with T2DM revealed an elevated serum level of IL-6</p><p>(637.1 pg/ml 355.9) compared to control group (266.3 pg/ml 128.8). IL4 590 C/T</p><p>displayed that C allele is a major allele in the studied group. The CC genotype has an</p><p>association with T2DM and this genotype increases the probability of contracting the</p><p>T2DM with an odds ratio (OR) = 1.2222. The genetic polymorphism of IL6 174G/C</p><p>patients with T2DM showed a significant frequency (chi-square = 0.601, p = 0.001) of</p><p>IL-6 G/C genotype (31.25%) in comparison with controls (23%). IL6 174G/C</p><p>displayed that G allele is a major allele in the studied group. As a conclusion, the levels</p><p>of IL-4 may not be associated with T2DM, whereas, the elevated levels of IL-6 may be</p><p>related with T2DM. The study implicates that functional gene polymorphisms of IL-4</p><p>and IL-6 will provide additional information related to the pathogenesis of diabetes</p><p>mellitus.</p> 2021 thesis https://ir.upsi.edu.my/detailsg.php?det=7334 https://ir.upsi.edu.my/detailsg.php?det=7334 text eng closedAccess Masters Universiti Pendidikan Sultan Idris Fakulti Sains dan Matematik <p>Ali, O. (2013). Genetics of type 2 diabetes. World Journal of Diabetes, 4(4), 114.</p><p></p><p>Al-Goblan, A. S., Al-Alfi, M. A., & Khan, M. Z. (2014). Mechanism linking diabetes</p><p>mellitus and obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and</p><p>Therapy, 7, 587.</p><p></p><p>Abd-Elbaky, A. E., Abo-El Matty, D. M., Mesbah, N. M., Saleh, S. M., & Hamid, A.</p><p>M. A. (2016). Adiponectin (+ 276 G/T), Tumor Necrosis Factor-alpha (-308 G/A)</p><p>and Interleukin-6 (-174 C/G) Genes Polymorphisms in Egyptian Type 2 Diabetic</p><p>Patients. Journal of Diabetes & Metabolism, 7(6).</p><p></p><p>Acharya, A. B., Thakur, S., Muddapur, M. V., & Kulkarni, R. D. (2016). Tumor</p><p>necrosis factor-, interleukin-4 and-6 in the serum of health, chronic periodontitis,</p><p>and type 2 diabetes mellitus. Journal of Indian Society of Periodontology, 20(5),</p><p>509.</p><p></p><p>Akdis, M., Aab, A., Altunbulakli, C., Azkur, K., Costa, R. A., Crameri, R., & Frei, R.</p><p>(2016). Interleukins (from IL-1 to IL-38), interferons, transforming growth factor</p><p>, and TNF-: Receptors, functions, and roles in diseases. Journal of Allergy and</p><p>Clinical Immunology, 138(4), 984-1010.</p><p></p><p>AL-Janaby, M. S., AL-Ani, M. Q., & Rasheed, M. N. (2018). Relationship between</p><p>some immunological factors and type 2 diabetes mellitus in Iraqi patients. Asian</p><p>Journal of Pharmaceutical and Clinical Research, 11(6), 489-492.</p><p></p><p>Ali, N. S. M., Allela, O. Q., Salih, H. M., & Ahmed, I. H. (2018). Prevalence of Type</p><p>2 Diabetes Associated Complications in Kurd-istan Region Iraq. Journal of Basic</p><p>and Clinical Pharmacy, 9(2), 263.</p><p></p><p>Albrechtsen, A., Grarup, N., Li, Y., Spars, T., Tian, G., Cao, H., & Nie, C. (2013).</p><p>Exome sequencing-driven discovery of coding polymorphisms associated with</p><p>common metabolic phenotypes. Diabetologia, 56(2), 298-310.</p><p></p><p>Alsaid, A., El-Missiry, M., Hatata, E. S., Tarabay, M., & Settin, A. (2013). Association</p><p>of IL-4-590 C> T and IL-13-1112 C> T gene polymorphisms with the</p><p>susceptibility to Type 2 diabetes mellitus. Disease Markers, 35(4), 243-247.</p><p></p><p>Arababadi, M. K. (2010). Interleukin-4 gene polymorphisms in type 2 diabetic patients</p><p>with nephropathy. Iranian Journal of Kidney Diseases, 4(4), 302.</p><p></p><p>Ashif, C. M., Balasubramanian, T., & Pawan Kumar and Fasalu Rahiman, O. M.</p><p>(2017). Interleukin-6 (IL-6) gene polymorphisms associated with type 2 diabetes</p><p>mellitus in Kerala population. International Journal of Medical Research and</p><p>Pharmaceutical Sciences, 4 (1).</p><p></p><p>Assmann, T. S., de Almeida Brondani, L., Bauer, A. C., Canani, L. H., & Crispim, D.</p><p>(2014). Polymorphisms in the TLR3 gene are associated with risk for type 1 diabetes mellitus.</p><p>European Journal of Endocrinology, 170(4), 519-527.</p><p></p><p>Animaw, W., & Seyoum, Y. (2017). Increasing prevalence of diabetes mellitus in a developing country</p><p>and its related factors. Plos One, 12(11), e0187670.</p><p></p><p>Akash, M. S. H., Rehman, K., & Liaqat, A. (2018). Tumor necrosis factor-alpha: role in development</p><p>of insulin resistance and pathogenesis of type 2 diabetes mellitus. Journal of Cellular</p><p>Biochemistry, 119(1), 105-110.</p><p></p><p>Abbatecola, A. M., Ferrucci, L., Grella, R., Bandinelli, S., Bonaf, M., Barbieri, M., & Paolisso,</p><p>G. (2004). Diverse effect of inflammatory markers on insulin resistance and insulin-resistance</p><p>syndrome in the elderly. Journal of the American Geriatrics Society, 52(3), 399-404.</p><p></p><p>Ates, I. (2018). Type 2 diabetes mechanisms, role of cytokines and their variations in disease</p><p>development. FABAD Journal of Pharmaceutical Sciences, 43(1), 31-40.</p><p></p><p>Acharya, A. B., Thakur, S., Muddapur, M. V., & Kulkarni, R. D. (2016). Tumor necrosis factor-,</p><p>interleukin-4 and-6 in the serum of health, chronic periodontitis, and type 2 diabetes mellitus.</p><p>Journal of Indian Society of Periodontology, 20(5), 509.</p><p></p><p>Abrahamian, H., Endler, G., Exner, M., Mauler, H., Raith, M., Endler, L., & Irsigler,</p><p>K. (2007). Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role</p><p>of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.</p><p>Experimental and Clinical Endocrinology & Diabetes, 115(01), 38-41.</p><p></p><p>Arora, P., Garcia-Bailo, B., Dastani, Z., Brenner, D., Villegas, A., Malik, S., & Badawi,</p><p>A. (2011). Genetic polymorphisms of innate immunity-related inflammatory pathways and their</p><p>association with factors related to type 2 diabetes. BMC Medical Genetics, 12(1), 95.</p><p></p><p>Banerjee, M., & Saxena, M. 2014. Genetic Polymorphisms of Cytokine Genes in Type 2 Diabetes</p><p>Mellitus. World Journal of Diabetes, 5 5(4): 493.</p><p></p><p>Banerjee, M., & Saxena, M. (2012). Interleukin-1 (IL-1) family of cytokines: role in type 2</p><p>diabetes. Clinica Chimica Acta, 413(15-16), 1163-1170.</p><p></p><p>Barry, J. C., Shakibakho, S., Durrer, C., Simtchouk, S., Jawanda, K. K., Cheung, S. T., & Little,</p><p>J. P. (2016). Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2</p><p>diabetes. Scientific Reports, 6, 21244.</p><p></p><p>Baynes, H. W. (2015). Classification, pathophysiology, diagnosis and management of diabetes</p><p>mellitus. Journal of Diabetes Metabolism, 6(5), 1-9.</p><p></p><p>Boutens, L., & Stienstra, R. (2016). Adipose tissue macrophages: going off track during</p><p>obesity. Diabetologia, 59(5), 879-894.</p><p></p><p>Beltcheva, O., Boyadzhieva, M., Angelova, O., Mitev, V., Kaneva, R., & Atanasova, I.</p><p>(2014). The rs266729 single-nucleotide polymorphism in the adiponectin gene</p><p>shows association with gestational diabetes. Archives of Gynecology and</p><p>Obstetrics, 289(4), 743-748.</p><p></p><p>Boucher, J., Kleinridders, A., & Kahn, C. R. (2014). Insulin receptor signaling in</p><p>normal and insulin-resistant states. Cold Spring Harbor Perspectives in</p><p>Biology, 6(1), a009191.</p><p></p><p>Bennet, L., Johansson, S. E., Agardh, C. D., Groop, L., Sundquist, J., Rstam, L., &</p><p>Sundquist, K. (2011). High prevalence of type 2 diabetes in Iraqi and Swedish</p><p>residents in a deprived Swedish neighbourhood-a population based study. BMC</p><p>Public Health, 11(1), 303.</p><p></p><p>Bonnycastle, L. L., Chines, P. S., Hara, T., Huyghe, J. R., Swift, A. J., Heikinheimo,</p><p>P, & Narisu, N. (2013). Autosomal dominant diabetes arising from a Wolfram</p><p>syndrome 1 mutation. Diabetes Journal, 62(11), 3943-3950.</p><p>bt Khazaai, H. (2018). Review on Potential Vitamin D Mechanism with Type 2</p><p>Diabetes Mellitus Pathophysiology in Malaysia. Current Research in Nutrition</p><p>and Food Science Journal, 6(1), 01-11.</p><p></p><p>Bid, H., Konwar, R., Agrawal, C., & Banerjee, M. (2008). Association of IL-4 and IL-</p><p>1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a</p><p>study in the north Indian population. Indian Journal of Medical Sciences, 62(7),</p><p>259-266.</p><p></p><p>Bonnefond, A., & Froguel, P. (2015). Rare and common genetic events in type 2</p><p>diabetes: what should biologists know?. Cell Metabolism, 21(3), 357-368.</p><p></p><p>Bai, H., Jing, D., Guo, A., & Yin, S. (2014). Association between interleukin 10 gene</p><p>polymorphisms and risk of type 2 diabetes mellitus in a Chinese</p><p>population. Journal of International Medical Research, 42(3), 702-710.</p><p></p><p>Bouhaha, R., Baroudi, T., Ennafaa, H., Vaillant, E., Abid, H., Sassi, R., & Vaxillaire,</p><p>M. (2010). Study of TNF-308G/A and IL6-174G/C polymorphisms in type 2</p><p>diabetes and obesity risk in the Tunisian population. Clinical Biochemistry, 43(6),</p><p>549-552.</p><p></p><p>Carpov, S., & Tortech, T. (2018). Secure top most significant genome variants search:</p><p>iDASH 2017 competition. BMC Medical Genomics, 11(4), 82.</p><p></p><p>Chang, H. W., Li, Y. H., Hsieh, C. H., Liu, P. Y., & Lin, G. M. (2016). Association of</p><p>body mass index with all-cause mortality in patients with diabetes: a systemic</p><p>review and meta-analysis. Cardiovascular Diagnosis and Therapy, 6(2), 109.</p><p></p><p>Chukwuani, U., Digban, K. A., Yovwin, G. D., & Chukwuebuni, N. J. (2016).</p><p>Prevalence of chronic complications of type 2 diabetes mellitus in a secondary</p><p>health centre in Niger Delta, Nigeria. International Journal of Research in</p><p>Medical Sciences, 4(4), 1080-1085.</p><p></p><p>Cieslak, Marek, Andrzej Wojtczak, and Michal Cieslak. 2015. Role of Pro-</p><p>Inflammatory Cytokines of Pancreatic Islets and Prospects of Elaboration of New</p><p>Methods for the Diabetes Treatment. Acta Biochimica Polonica 62(1): 1521.</p><p></p><p>Chen, G., Bentley, A., Adeyemo, A., Shriner, D., Zhou, J., Doumatey, A., & Herbert,</p><p>A. (2012). Genome-wide association study identifies novel loci association with</p><p>fasting insulin and insulin resistance in African Americans. Human molecular</p><p>genetics, 21(20), 4530-4536.</p><p></p><p>Cho, Y. S., Chen, C. H., Hu, C., Long, J., Ong, R. T. H., Sim, X., & Chang, Y. C.</p><p>(2012). Meta-analysis of genome-wide association studies identifies eight new loci</p><p>for type 2 diabetes in east Asians. Nature Genetics, 44(1), 67.</p><p></p><p>Chang, Y. H., Huang, C. N., & Shiau, M. Y. (2004). The C-174G promoter</p><p>polymorphism of the interleukin-6 (IL-6) gene that affects insulin sensitivity in</p><p>Caucasians is not involved in the pathogenesis of Taiwanese type 2 diabetes</p><p>mellitus. European Cytokine Network, 15(2), 117-119.</p><p></p><p>De Bruijn, K. M. J., Arends, L. R., Hansen, B. E., Leeflang, S., Ruiter, R., & Van Eijck,</p><p>C. H. J. (2013). Systematic review and meta-analysis of the association between</p><p>diabetes mellitus and incidence and mortality in breast and colorectal</p><p>cancer. British Journal of Surgery, 100(11), 1421-1429.</p><p></p><p>Dorajoo, R., Liu, J., & Boehm, B. (2015). Genetics of type 2 diabetes and clinical</p><p>utility. Genes, 6(2), 372-384.</p><p></p><p>Dupuis, J., Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., Jackson, A. U., &</p><p>Lindgren, C. M. (2010). New genetic loci implicated in fasting glucose</p><p>homeostasis and their impact on type 2 diabetes risk. Nature Genetics, 42(2), 105-</p><p>116.</p><p></p><p>Dragsbk, K., Neergaard, J. S., Laursen, J. M., Hansen, H. B., Christiansen, C., Beck-</p><p>Nielsen, H., & Henriksen, K. 2016. Metabolic Syndrome and Subsequent Risk of</p><p>Type 2 Diabetes and Cardiovascular Disease in Elderly Women. Medicine, 95 36.</p><p></p><p>Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018). Prevalence of</p><p>cardiovascular disease in type 2 diabetes: a systematic literature review of</p><p>scientific evidence from across the world in 20072017. Cardiovascular</p><p>Diabetology, 17(1), 83.</p><p></p><p>Elbe-Burger, A., Olt, S., Stingl, G., Egyed, A., Klubal, R., Mann, U., & Rot, A.</p><p>(2002). Overexpression of IL-4 alters the homeostasis in the skin. Journal of</p><p>Investigative Dermatology, 118(5), 767-778.</p><p></p><p>Erbagci, A. B., Tarakioglu, M., Coskun, Y., Sivasli, E., & Namiduru, E. S. (2001).</p><p>Mediators of inflammation in children with type I diabetes mellitus: cytokines</p><p>type I diabetic children. Clinical Biochemistry, 34(8), 645-650.</p><p></p><p>Elek, Z., Nmeth, N., Nagy, G., Nmeth, H., Somogyi, A., Hosszufalusi, N., & Rnai,</p><p>Z. (2015). Micro-RNA binding site polymorphisms in the WFS1 gene are risk</p><p>factors of diabetes mellitus. Plos One, 10(10), e0139519.</p><p></p><p>Erem, C., Kuzu, U. B., Deger, O., & Can, G. (2015). Prevalence of gestational diabetes</p><p>mellitus and associated risk factors in Turkish women: the Trabzon GDM</p><p>Study. Archives of Medical Science: AMS, 11(4), 724.</p><p></p><p>Festa, A., DAgostino, R., Tracy, R. P., & Haffner, S. M. (2002). Elevated levels of</p><p>acute-phase proteins and plasminogen activator inhibitor-1 predict the</p><p>development of type 2 diabetes: the insulin resistance atherosclerosis</p><p>study. Diabetes, 51(4), 1131-1137.</p><p></p><p>Flannick, J., & Florez, J. C. (2016). Type 2 diabetes: genetic data sharing to advance</p><p>complex disease research. Nature Reviews Genetics, 17(9), 535.</p><p></p><p>Forbes, J. M., & Cooper, M. E. (2013). Mechanisms of diabetic</p><p>complications. Physiological Reviews, 93(1), 137-188.</p><p></p><p>Fernndez-Real, J. M., Broch, M., Vendrell, J., Gutirrez, C., Casamitjana, R., Pugeat,</p><p>M., ... & Ricart, W. (2000). Interleukin-6 gene polymorphism and insulin</p><p>sensitivity. Diabetes, 49(3), 517-520.</p><p></p><p>Galavi, H. R., Saravani, R., Alamdari, A. R., Ranjbar, N., Damani, E., & Khodakhier,</p><p>T. N. (2016). Evaluating the effect of the rs2229238 and the rs4845625 interleukin</p><p>6 receptor gene polymorphisms on body mass index and the risk of type 2 diabetes</p><p>in an iranian study population. International Journal of High Risk Behaviors and</p><p>Addiction, 5(4).</p><p></p><p>Gupta, D. L., Nagar, P. K., Kamal, V. K., Bhoi, S., & Rao, D. N. (2015). Clinical</p><p>relevance of single nucleotide polymorphisms within the 13 cytokine genes in</p><p>North Indian trauma hemorrhagic shock patients. Scandinavian Journal of</p><p>Trauma, Resuscitation and Emergency Medicine, 23(1), 96.</p><p></p><p>Gao, K., Ren, Y., Wang, J., Liu, Z., Li, J., Li, L., & Ohno, K. 2017. Interactions between</p><p>Genetic Polymorphisms of Glucose Metabolizing Genes and Smoking and</p><p>Alcohol Consumption in the Risk of Type 2 Diabetes Mellitus. Applied</p><p>Physiology, Nutrition, and Metabolism, 42: 124.</p><p></p><p>Geerlings, S. E., Brouwer, E. C., Van Kessel, K. C., Gaastra, W., Stolk, R. P., &</p><p>Hoepelman, A. I. (2000). Cytokine secretion is impaired in women with diabetes</p><p>mellitus. European Journal of Clinical Investigation, 30(11), 995-1001.</p><p></p><p>Grarup, N., Sandholt, C. H., Hansen, T., & Pedersen, O. (2014). Genetic susceptibility</p><p>to type 2 diabetes and obesity: from genome-wide association studies to rare</p><p>variants and beyond. Diabetologia, 57(8), 1528-1541.</p><p></p><p>Gulati, K., Guhathakurta, S., Joshi, J., Rai, N., & Ray, A. (2016). Cytokines and their</p><p>role in health and disease: a brief overview. MedCrave Online Journal of</p><p>Immunology, 4(2), 00121.</p><p></p><p>Go, M. J., Hwang, J. Y., Kim, Y. J., Oh, J. H., Kim, Y. J., Kwak, S. H., & Cho, M. C.</p><p>(2013). New susceptibility loci in MYL2, C12orf51 and OAS1 associated with 1-</p><p>h plasma glucose as predisposing risk factors for type 2 diabetes in the Korean</p><p>population. Journal of Human Genetics, 58(6), 362-365.</p><p></p><p>Gudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G.,</p><p>Manolescu, A., & Sigurdsson, A. (2007). Two variants on chromosome 17 confer</p><p>prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nature</p><p>Genetics, 39(8), 977-983.</p><p></p><p>Grant, S. F., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz,</p><p>J., & Styrkarsdottir, U. (2006). Variant of transcription factor 7-like 2 (TCF7L2)</p><p>gene confers risk of type 2 diabetes. Nature Genetics, 38(3), 320-323.</p><p></p><p>Gupta, S., Maratha, A., Siednienko, J., Natarajan, A., Gajanayake, T., Hoashi, S., &</p><p>Miggin, S. (2017). Analysis of inflammatory cytokine and TLR expression levels</p><p>in Type 2 Diabetes with complications. Scientific Reports, 7(1), 7633.</p><p></p><p>Guzmn-Flores, J. M., Escalante, M., Snchez-Corona, J., Garca-Zapin, A. G., Cruz-</p><p>Quevedo, E. G., Munoz-Valle, J. F., & Flores-Martnez, S. E. (2013). Association</p><p>analysis between308G/A and238G/A TNF-alpha gene promoter</p><p>polymorphisms and insulin resistance in Mexican women with gestational</p><p>diabetes mellitus. Journal of Investigative Medicine, 61(2), 265-269.</p><p></p><p>Groop, L. C., Saloranta, C., Shank, M., Bonadonna, R. C., Ferrannini, E., & Defronzo,</p><p>R. A. (1991). The role of free fatty acid metabolism in the pathogenesis of insulin</p><p>resistance in obesity and noninsulin-dependent diabetes mellitus. The Journal of</p><p>Clinical Endocrinology and Metabolism, 72(1), 96-107.</p><p></p><p>Hartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., & Donovan, L.</p><p>(2013). Benefits and harms of treating gestational diabetes mellitus: a systematic</p><p>review and meta-analysis for the US Preventive Services Task Force and the</p><p>National Institutes of Health Office of Medical Applications of Research. Annals</p><p>of Internal Medicine, 159(2), 123-129.</p><p></p><p>Hashizume, M., and Mihara, M. (2011). IL-6 and lipid metabolism. Inflammation and</p><p>Regeneration, 31(3), 325-333.</p><p></p><p>Helaly, M. A. H., Hatata, E. S. Z., Abu-Elmagd, M., Ibrahem, E. F., Alsaid, A., El-Aal,</p><p>A. & Settin, A. (2013). Association of IL-10 and IL-6 Gene Polymorphisms with</p><p>Type 2 Diabetes Mellitus among Egyptian Patients. European Journal of General</p><p>Medicine, 10(3).</p><p></p><p>Ho, K. T., Shiau, M. Y., Chang, Y. H., Chen, C. M., Yang, S. C., & Huang, C. N.</p><p>(2010). Association of interleukin-4 promoter polymorphisms in Taiwanese</p><p>patients with type 2 diabetes mellitus. Metabolism, 59(12), 1717-1722.</p><p></p><p>Hu, C., & Jia, W. (2018). Diabetes in China: epidemiology and genetic risk factors and</p><p>their clinical utility in personalized medication. Diabetes, 67(1), 3-11.</p><p>Hu, Y., Bhupathiraju, S. N., Koning, L., & Hu, F. B. (2014). Duration of obesity and</p><p>overweight and risk of type 2 diabetes among US women. Obesity, 22(10), 2267-</p><p>2273.</p><p></p><p>Huang, Z. Q., Liao, Y. Q., Huang, R. Z., Chen, J. P., & Sun, H. L. (2018). Possible role</p><p>of TCF7L2 in the pathogenesis of type 2 diabetes mellitus. Biotechnology and</p><p>Biotechnological Equipment, 32(4), 830-834.</p><p></p><p>Hussain, M. K., Deli, F. A., Algenabi, A. H. A., & Abdul-Rudha, K. H. (2018).</p><p>Adiponectin gene polymorphisms as a predictor for development of type 2</p><p>diabetes mellitus in Iraqi population. Gene, 662, 118-122.</p><p></p><p>Huth, C., Illig, T., Herder, C., Gieger, C., Grallert, H., Vollmert, C., & Thorand, B.</p><p>(2009). Joint analysis of individual participants data from 17 studies on the</p><p>association of the IL6 variant-174G> C with circulating glucose levels,</p><p>interleukin-6 levels, and body mass index. Annals of Medicine, 41(2), 128-138.</p><p></p><p>Himelfarb, S. T., Silva, F. A., Arazi, S. S., Farjado, C. M., Garofalo, A., Bertolami, M.</p><p>C & Hirata, R. D. (2011). Tumor necrosis factor- and interleukin-6 expression in</p><p>leukocytes and their association with polymorphisms and bone markers in diabetic</p><p>individuals treated with pioglitazone. Drug Metabolism and Drug</p><p>Interactions, 26(1), 37-40.</p><p></p><p>Herbert, A., Liu, C., Karamohamed, S., Schiller, J., Liu, J., Yang, Q., & Meigs, J. B.</p><p>(2005). The174 IL-6 GG genotype is associated with a reduced risk of type 2</p><p>diabetes mellitus in a family sample from the National Heart, Lung and Blood</p><p>Institutes Framingham Heart Study. Diabetologia, 48(8), 1492-1495.</p><p></p><p>Huth, C., Heid, I. M., Vollmert, C., Gieger, C., Grallert, H., Wolford, J. K., & Pedersen,</p><p>O. (2006). IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis</p><p>of individual participants data from 21 studies. Diabetes, 55(10), 2915-2921.</p><p></p><p>Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995).</p><p>Increased adipose tissue expression of tumor necrosis factor-alpha in human</p><p>obesity and insulin resistance. The Journal of Clinical Investigation, 95(5), 2409-</p><p>2415.</p><p></p><p>Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B.</p><p>M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity</p><p>in TNF--and obesity-induced insulin resistance. Science, 271(5249), 665-670.</p><p></p><p>Illig, T., Bongardt, F., Schpfer-Wendels, A., Huth, C., Heid, I., Rathmann, W., &</p><p>Wichmann, H. E. (2005). Genetics of type 2 diabetes: impact of interleukin-6 gene</p><p>variants. Das Gesundheitswesen, 67(S 01), 122-126.</p><p></p><p>Illig, T., Bongardt, F., Schopfer, A., Muller-Scholze, S., Rathmann, W., Koenig, W., &</p><p>Herder, C. (2004). Significant association of the interleukin-6 gene</p><p>polymorphisms C-174G and A-598G with type 2 diabetes. The Journal of Clinical</p><p>Endocrinology and Metabolism, 89(10), 5053-5058.</p><p></p><p>Jain, S. K., Kannan, K., Lim, G., Matthews-Greer, J., McVie, R., & Bocchini, J. A.</p><p>(2003). Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic</p><p>patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes</p><p>Care, 26(7), 2139-2143.</p><p></p><p>Kwak, S. H., Choi, S. H., Kim, K., Jung, H. S., Cho, Y. M., Lim, S., & Jang, H. C.</p><p>(2013). Prediction of type 2 diabetes in women with a history of gestational</p><p>diabetes using a genetic risk score. Diabetologia, 56(12), 2556-2563.</p><p></p><p>Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014). Pathophysiology and treatment of</p><p>type 2 diabetes: perspectives on the past, present, and future. The</p><p>Lancet, 383(9922), 1068-1083.</p><p></p><p>Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006). Mechanisms linking obesity to</p><p>insulin resistance and type 2 diabetes. Nature, 444(7121), 840-846.</p><p></p><p>Kampan, N., Azman, H., Hafiz, I., Mohammad, H., Yee, C. S., & Abdul Ghani, N. A.</p><p>(2013). Outcome of pregnancy among Malaysian women with diabetes mellitus-</p><p>a single centre experience. Malaysian Journal of Public Health Medicine, 13(2),</p><p>1-10.</p><p></p><p>Karamanou, Marianna. 2016. Milestones in the History of Diabetes Mellitus: The Main</p><p>Contributors. World Journal of Diabetes 7(1): 1.</p><p></p><p>Kaul, N., & Ali, S. (2016). Genes, genetics, and environment in type 2 diabetes:</p><p>implication in personalized medicine. DNA and Cell Biology, 35(1), 1-12.</p><p></p><p>Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016). Sex and gender differences in</p><p>risk, pathophysiology and complications of type 2 diabetes mellitus. Endocrine</p><p>Reviews, 37(3), 278-316.</p><p></p><p>Keith, R. J., Al Rifai, M., Carruba, C., De Jarnett, N., McEvoy, J. W., Bhatnagar, A.,</p><p>... & Defilippis, A. P. (2016). Tobacco use, insulin resistance, and risk of type 2</p><p>diabetes: results from the multi-ethnic study of atherosclerosis. PLoS One, 11(6),</p><p>e0157592.</p><p></p><p>Kiani, A., Garcia-Czar, F. J., Habermann, I., Laforsch, S., Aebischer, T., Ehninger,</p><p>G., & Rao, A. (2001). Regulation of interferon- gene expression by nuclear factor</p><p>of activated T cells. Blood, 98(5), 1480-1488.</p><p></p><p>Kim, A. Y., Park, Y. J., Pan, X., Shin, K. C., Kwak, S. H., Bassas, A. F., & Kim, J. B.</p><p>(2015). Obesity-induced DNA hypermethylation of the adiponectin gene mediates</p><p>insulin resistance. Nature Communications, 6, 7585.</p><p></p><p>Kolb, H., & Martin, S. (2017). Environmental/lifestyle factors in the pathogenesis and</p><p>prevention of type 2 diabetes. BioMed Central Medicine, 15(1), 131.</p><p></p><p>Kommoju, U. J., Samy, S. K., Maruda, J., Irgam, K., Kotla, J. P., Velaga, L., & Reddy,</p><p>B. M. (2016). Association of CDKAL1, CDKN2A/B & HHEX gene</p><p>polymorphisms with type 2 diabetes mellitus in the population of Hyderabad,</p><p>India. The Indian Journal of Medical Research, 143(4), 455.</p><p></p><p>Kong, Y., Sharma, R. B., Nwosu, B. U., & Alonso, L. C. (2016). Islet biology, the</p><p>CDKN2A/B locus and type 2 diabetes risk. Diabetologia, 59(8), 1579-1593.</p><p></p><p>Kristiansen, O. P., & Mandrup-Poulsen, T. (2005). Interleukin-6 and diabetes: the good,</p><p>the bad, or the indifferent?. Diabetes, 54(suppl 2), S114-S124.</p><p></p><p>Kleiner, S., Gomez, D., Megra, B., Na, E., Bhavsar, R., Cavino, K., & Carrat, G. (2018).</p><p>Mice harboring the human SLC30A8 R138X loss-of-function mutation have</p><p>increased insulin secretory capacity. Proceedings of the National Academy of</p><p>Sciences, 115(32), E7642-E7649.</p><p></p><p>Kubaszek, A., Pihlajamki, J., Punnonen, K., Karhap, P., Vauhkonen, I., & Laakso,</p><p>M. (2003). The C-174G promoter polymorphism of the IL-6 gene affects energy</p><p>expenditure and insulin sensitivity. Diabetes, 52(2), 558-561.</p><p></p><p>Kabesch, M., Tzotcheva, I., Carr, D., Hfler, C., Weiland, S. K., Fritzsch, C., &</p><p>Martinez, F. D. (2003). A complete screening of the IL4 gene: novel</p><p>polymorphisms and their association with asthma and IgE in childhood. Journal</p><p>of Allergy and Clinical Immunology, 112(5), 893-898.</p><p></p><p>Kwak, S. H., & Park, K. S. (2016). Recent progress in genetic and epigenetic research</p><p>on type 2 diabetes. Experimental and Molecular Medicine, 48(3), e220.</p><p></p><p>Kooner, J. S., Saleheen, D., Sim, X., Sehmi, J., Zhang, W., Frossard, P., & Jafar, T.</p><p>(2011). Genome-wide association study in individuals of South Asian ancestry</p><p>identifies six new type 2 diabetes susceptibility loci. Nature Genetics, 43(10), 984-</p><p>989.</p><p></p><p>Kong, A., Steinthorsdottir, V., Masson, G., Thorleifsson, G., Sulem, P., Besenbacher,</p><p>S., & Frigge, M. L. (2009). Parental origin of sequence variants associated with</p><p>complex diseases. Nature, 462(7275), 868-874.</p><p></p><p>Kilpelinen, T. O., Laaksonen, D. E., Lakka, T. A., Herder, C., Koenig, W., Lindstrm,</p><p>J., & Tuomilehto, J. (2010). The rs1800629 polymorphism in the TNF gene</p><p>interacts with physical activity on the changes in C-reactive protein levels in the</p><p>Finnish Diabetes Prevention Study. Experimental and Clinical Endocrinology and</p><p>Diabetes, 118(10), 757-759.</p><p></p><p>Kulseng, B., Skjk-Braek, G., Flling, I., & Espevik, T. (1996). TNF production from</p><p>peripheral blood mononuclear cells in diabetic patients after stimulation with</p><p>alginate and lipopolysaccharide. Scandinavian Journal of Immunology, 43(3),</p><p>335-340.</p><p></p><p>Kubaszek, A., Pihlajamki, J., Punnonen, K., Karhap, P., Vauhkonen, I., & Laakso,</p><p>M. (2003). The C-174G promoter polymorphism of the IL-6 gene affects energy</p><p>expenditure and insulin sensitivity. Diabetes, 52(2), 558-561.</p><p></p><p>Kieffer, T. J., Heller, R. S., Leech, C. A., Holz, G. G., & Habener, J. F. (1997). Leptin</p><p>suppression of insulin secretion by the activation of ATP-sensitive K+ channels in</p><p>pancreatic -cells. Diabetes, 46(6), 1087-1093.</p><p></p><p>Lakhtakia, R. 2013. The History of Diabetes Mellitus. Sultan Qaboos University</p><p>Medical Journal, 13 15(4): 33642.</p><p></p><p>Lazic, M., Inzaugarat, M. E., Povero, D., Zhao, I. C., Chen, M., Nalbandian, M., &</p><p>Sears, D. D. (2014). Reduced dietary omega-6 to omega-3 fatty acid ratio and</p><p>12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced</p><p>steatohepatitis. PloS One, 9(9), e107658.</p><p></p><p>Le, T. N., Elsea, S. H., Romero, R., Chaiworapongsa, T., & Francis, G. L. (2013).</p><p>Prolactin receptor gene polymorphisms are associated with gestational</p><p>diabetes. Genetic Testing and Molecular Biomarkers, 17(7), 567-571.</p><p></p><p>Liao, W. L., & Tsai, F. J. (2014). Personalized Medicine in Type 2 Diabetes. Bio</p><p>Medicine, 4 4(2): 18.</p><p></p><p>Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007). Obesity induces a phenotypic</p><p>switch in adipose tissue macrophage polarization. The Journal of Clinical</p><p>Investigation, 117(1), 175-184.</p><p></p><p>Liese, Angela D., Xiaoguang Ma, David M. Maahs, and Jennifer L. Trilk. 2013.</p><p>Physical Activity, Sedentary Behaviors, Physical Fitness, and Their Relation to</p><p>Health Outcomes in Youth with Type 1 and Type 2 Diabetes: A Review of the</p><p>Epidemiologic Literature. Journal of Sport and Health Science, 2(1): 2138.</p><p></p><p>Lim, S., Kim, M. J., Lim, S., Kim, M. J., Choi, S. H., Shin, C. S., & Choi, S. H. (2013).</p><p>Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk</p><p>Asian subjects. The American Journal of Clinical Nutrition, 97(3), 524-530.</p><p></p><p>Lips, P., Eekhoff, M., van Schoor, N., Oosterwerff, M., de Jongh, R., Krul-Poel, Y., &</p><p>Simsek, S. (2017). Vitamin D and type 2 diabetes. The Journal of Steroid</p><p>Biochemistry and Molecular Biology, 173, 280-285.</p><p></p><p>Li, H., Gan, W., Lu, L., Dong, X., Han, X., Hu, C., & He, M. (2013). A genome-wide</p><p>association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in</p><p>Chinese Hans. Diabetes, 62(1), 291-298.</p><p></p><p>Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007). Obesity induces a phenotypic</p><p>switch in adipose tissue macrophage polarization. The Journal of Clinical</p><p>Investigation, 117(1), 175-184.</p><p></p><p>Little, S. (1995). Amplification-refractory mutation system (ARMS) analysis of point</p><p>mutations. Current Protocols in Human Genetics, 7(1), 9-8.</p><p></p><p>Logakodie, S., Azahadi, O., Fuziah, P., Norizzati, B. I. B., Tan, S. F., Zienna, Z. Z. R.,</p><p>& Sazidah, M. K. (2017). Gestational diabetes mellitus: The prevalence,</p><p>associated factors and foeto-maternal outcome of women attending antenatal</p><p>care. Malaysian family Physician: the Official journal of the Academy of Family</p><p>Physicians of Malaysia, 12(2), 9.</p><p></p><p>Luo, W., Guo, Z., Wu, M., Hao, C., Zhou, Z., & Yao, X. (2015). Interaction of smoking</p><p>and obesity on type 2 diabetes risk in a Chinese cohort. Physiology and</p><p>Behavior, 139, 240-243.</p><p></p><p>Lyssenko, V., & Laakso, M. (2013). Genetic screening for the risk of type 2 diabetes:</p><p>worthless or valuable?. Diabetes Care, 36(Supplement 2), S120-S126.</p><p></p><p>Libra, M., Signorelli, S. S., Bevelacqua, Y., Navolanic, P. M., Bevelacqua, V., Polesel,</p><p>J., & Malaponte, G. (2006). Analysis of G (-174) C IL-6 polymorphism and</p><p>plasma concentrations of inflammatory markers in patients with type 2 diabetes</p><p>and peripheral arterial disease. Journal of Clinical Pathology, 59(2), 211-215.</p><p></p><p>Maier, L. M., Chapman, J., Howson, J. M., Clayton, D. G., Pask, R., Strachan, D. P., &</p><p>Todd, J. A. (2005). No evidence of association or interaction between the IL4RA,</p><p>IL4, and IL13 genes in type 1 diabetes. The American Journal of Human</p><p>Genetics, 76(3), 517-521.</p><p></p><p>Malenica, M., ilar, M., Dujic, T., Bego, T., Semiz, S., krbo, S., & Cauevic, A.</p><p>(2017). Importance of inflammatory markers and IL-6 for diagnosis and follow up</p><p>of patients with type 2 diabetes mellitus. Medicinski Glasnik, 14(2).</p><p></p><p>Mansour, A., & Al Douri, F. (2015). Diabetes in Iraq: facing the epidemic. A systematic</p><p>review. Wulfenia Journal, 22(3), 258-73.</p><p></p><p>Martinez, F. O., Sica, A., Mantovani, A., & Locati, M. (2008). Macrophage activation</p><p>and polarization. Front Bioscience, 13(1), 453-461.</p><p></p><p>Mohlke, K. L., & Boehnke, M. (2015). Recent advances in understanding the genetic</p><p>architecture of type 2 diabetes. Human Molecular Genetics, 24(R1), R85-R92.</p><p></p><p>Meybodi, H. R. A., Hasanzad, M., & Larijani, B. (2017). Path to personalized medicine</p><p>for type 2 diabetes mellitus: reality and hope. Acta Medica Iranica, 166-174.</p><p></p><p>Mendoza-Carrera, F., Ramrez-Lpez, G., Ayala-Martnez, N. A., Garca-Zapin, A.</p><p>G., Flores-Martnez, S. E., & Snchez-Corona, J. (2010). Influence of CRP, IL6,</p><p>and TNFA gene polymorphisms on circulating levels of C-reactive protein in</p><p>Mexican adolescents. Archives of Medical Research, 41(6), 472-477.</p><p></p><p>Manning, A. K., Hivert, M. F., Scott, R. A., Grimsby, J. L., Bouatia-Naji, N., Chen, H.,</p><p>... & Amin, N. (2012). A genome-wide approach accounting for body mass index</p><p>identifies genetic variants influencing fasting glycemic traits and insulin</p><p>resistance. Nature Genetics, 44(6), 659-669.</p><p></p><p>Martn-Timn, I., Sevillano-Collantes, C., Segura-Galindo, A., & del Caizo-Gmez,</p><p>F. J. (2014). Type 2 diabetes and cardiovascular disease: have all risk factors the</p><p>same strength?. World Journal of Diabetes, 5(4), 444.</p><p></p><p>Morris, A. P., Voight, B. F., Teslovich, T. M., Ferreira, T., Segre, A. V.,</p><p>Steinthorsdottir, V., & Prokopenko, I. (2012). Large-scale association analysis</p><p>provides insights into the genetic architecture and pathophysiology of type 2</p><p>diabetes. Nature Genetics, 44(9), 981.</p><p></p><p>Mukhopadhyaya, P. N., Acharya, A., Chavan, Y., Purohit, S. S., & Mutha, A. (2010).</p><p>Metagenomic study of single-nucleotide polymorphism within candidate genes</p><p>associated with type 2 diabetes in an Indian population. Genetics and Molecular</p><p>Research, 9(4), 2060-8.</p><p></p><p>Mostafazadeh, A., Herder, C., Haastert, B., Hanifi-Moghaddam, P., Schloot, N.,</p><p>Koenig, W., & Kolb, H. (2005). Association of humoral immunity to human</p><p>Hsp60 with the IL-6 gene polymorphism C-174G in patients with type 2 diabetes</p><p>and controls. Hormone and Metabolic Research, 37(04), 257-263.</p><p></p><p>Mohlig, M., Boeing, H., Spranger, J., Osterhoff, M., Kroke, A., Fisher, E. V. A., &</p><p>Pfeiffer, A. F. (2004). Body mass index and C-174G interleukin-6 promoter</p><p>polymorphism interact in predicting type 2 diabetes. The Journal of Clinical</p><p>Endocrinology and Metabolism, 89(4), 1885-1890.</p><p></p><p>McNeely, M. J., Boyko, E. J., Weigle, D. S., Shofer, J. B., Chessler, S. D., Leonnetti,</p><p>D. L., & Fujimoto, W. Y. (1999). Association between baseline plasma leptin</p><p>levels and subsequent development of diabetes in Japanese Americans. Diabetes</p><p>Care, 22(1), 65-70.</p><p></p><p>Mahajan, A., Go, M. J., Zhang, W., Below, J. E., Gaulton, K. J., Ferreira, T., &</p><p>Saleheen, D. (2014). Genome-wide trans-ancestry meta-analysis provides insight</p><p>into the genetic architecture of type 2 diabetes susceptibility. Nature</p><p>genetics, 46(3), 234-244.</p><p></p><p>Nakatochi, M., Ichihara, S., Yamamoto, K., Ohnaka, K., Kato, Y., Yokota, S., &</p><p>Matsubara, T. (2015). Epigenome-wide association study suggests that SNPs in</p><p>the promoter region of RETN influence plasma resistin level via effects on DNA</p><p>methylation at neighbouring sites. Diabetologia, 58(12), 2781-2790.</p><p></p><p>Nazamuddin, M., Wadud, A., Ansari, A. H., Alam, T., Perveen, A., & Iqbal, N. (2014).</p><p>Concept of diabetes in Unani system of medicine: an overview. Medical Journal</p><p>of Islamic World Academy of Sciences, 109(1567), 1-6.</p><p></p><p>Navarro-Gonzlez, J. F., Muros, M., Mora-Fernndez, C., Herrera, H., Meneses, B., &</p><p>Garca, J. (2011). Pentoxifylline for renoprotection in diabetic nephropathy: the</p><p>PREDIAN study. Rationale and basal results. Journal of Diabetes and Its</p><p>Complications, 25(5), 314-319.</p><p></p><p>Ng, D. P., Nurbaya, S., Sandra, H. J., & Krolewski, A. S. (2008). An IL-6 haplotype on</p><p>human chromosome 7p21 confers risk for impaired renal function in type 2</p><p>diabetic patients. Kidney International, 74(4), 521-527.</p><p></p><p>Ng, M. C., Shriner, D., Chen, B. H., Li, J., Chen, W. M., Guo, X., & Comeau, M. E.</p><p>(2014). Meta-analysis of genome-wide association studies in African Americans</p><p>provides insights into the genetic architecture of type 2 diabetes. PLoS</p><p>Genetics, 10(8), e1004517.</p><p></p><p>Newton, C. R., Graham, A., Heptinstall, L. E., Powell, S. J., Summers, C., Kalsheker,</p><p>N., ... & Markham, A. F. (1989). Analysis of any point mutation in DNA. The</p><p>amplification refractory mutation system (ARMS). Nucleic Acids</p><p>Research, 17(7), 2503-2516.</p><p></p><p>Nuhiar, R. S., Salman, A. N., & AL-Rekaby, H. R. (2018). The some cytokines Levels</p><p>(TGF1, IL-4, IL-6, and IL-17) in sera Patients with Diabetes Mellitus Type1,</p><p>Type 2 in Nassiriya city. Journal of Thi-qar Science, 6(4), 42-48.</p><p></p><p>Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L.,</p><p>Cho, N. H., ... & Makaroff, L. E. (2017). IDF Diabetes Atlas: Global estimates for</p><p>the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical</p><p>Practice, 128, 40-50.</p><p></p><p>Olokoba, A. B., Obateru, O. A., & Olokoba, L. B. (2012). Type 2 diabetes mellitus: a</p><p>review of current trends. Oman Medical Journal, 27(4), 269.</p><p></p><p>Ozougwu, J. C., Obimba, K. C., Belonwu, C. D., & Unakalamba, C. B. (2013). The</p><p>pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal</p><p>of Physiology and Pathophysiology, 4(4), 46-57.</p><p></p><p>Okayama, H., Curiel, D. T., Brantly, M. L., Holmes, M. D., & Crystal, R. G. (1989).</p><p>Rapid, nonradioactive detection of mutations in the human genome by allelespecific</p><p>amplification. The Journal of Laboratory and Clinical Medicine, 114(2),</p><p>105-113.</p><p></p><p>Oberbach, A., Lehmann, S., Kirsch, K., Krist, J., Sonnabend, M., Linke, A., & Kovacs,</p><p>P. (2008). Long-term exercise training decreases interleukin-6 (IL-6) serum levels</p><p>in subjects with impaired glucose tolerance: effect of the 174G/C variant in IL-6</p><p>gene. European Journal of Endocrinology, 159(2), 129-136.</p><p></p><p>Oguntibeju, O. O. (2019). Type 2 diabetes mellitus, oxidative stress and inflammation:</p><p>examining the links. International Journal of Physiology, Pathophysiology and</p><p>Pharmacology, 11(3), 45.</p><p></p><p>Pan, A., Wang, Y., Talaei, M., Hu, F. B., & Wu, T. (2015). Relation of active, passive,</p><p>and quitting smoking with incident type 2 diabetes: a systematic review and metaanalysis.</p><p>The Lancet Diabetes and Endocrinology, 3(12), 958-967.</p><p></p><p>Papaetis, Georgios S, Panagiotis Papakyriakou, and Themistoklis N Panagiotou.</p><p>(2015). Central obesity , type 2 diabetes and insulin : exploring a pathway full of</p><p>thorns. Archives of Medical Science: AMS, 11(3), 463.</p><p></p><p>Patel, T. P., Rawal, K., Bagchi, A. K., Akolkar, G., Bernardes, N., da Silva Dias, D., &</p><p>Singal, P. K. (2016). Insulin resistance: an additional risk factor in the</p><p>pathogenesis of cardiovascular disease in type 2 diabetes. Heart Failure</p><p>Reviews, 21(1), 11-23.</p><p></p><p>Pesu, M., Takaluoma, K., Aittomki, S., Lagerstedt, A., Saksela, K., Kovanen, P. E., &</p><p>Silvennoinen, O. (2000). Interleukin-4-induced transcriptional activation by stat6</p><p>involves multiple serine/threonine kinase pathways and serine phosphorylation of</p><p>stat6. Blood, 95(2), 494-502.</p><p></p><p>Peters, S. A., Huxley, R. R., & Woodward, M. (2016). Sex differences in body</p><p>anthropometry and composition in individuals with and without diabetes in the</p><p>UK Biobank. British Medical Journal BMJ Open, 6(1), e010007.</p><p></p><p>Prasad, R., & Groop, L. (2015). Genetics of type 2 diabetespitfalls and</p><p>possibilities. Genes, 6(1), 87-123.</p><p></p><p>Popko, K., Gorska, E., & Demkow, U. (2010). Influence of interleukin-6 and G174C</p><p>polymorphism in IL-6 gene on obesity and energy balance. European Journal of</p><p>Medical Research, 15(2), 123.</p><p></p><p>Punthakee, Z., Goldenberg, R., & Katz, P. (2018). Definition, classification and</p><p>diagnosis of diabetes, prediabetes and metabolic syndrome. Canadian Journal of</p><p>Diabetes, 42, S10-S15.</p><p></p><p>Panagi, L., Poole, L., Hackett, R. A., & Steptoe, A. (2019). Sex differences in</p><p>interleukin-6 stress responses in people with Type 2 diabetes. Psychophysiology,</p><p>56(6), e13334.</p><p></p><p>Pradhan, A. D., Manson, J. E., Rifai, N., Buring, J. E., & Ridker, P. M. (2001). Creactive</p><p>protein, interleukin 6, and risk of developing type 2 diabetes mellitus.</p><p>Jama, 286(3), 327-334.</p><p></p><p>Perry, J. R., Voight, B. F., Yengo, L., Amin, N., Dupuis, J., Ganser, M., &</p><p>Steinthorsdottir, V. (2012). Stratifying type 2 diabetes cases by BMI identifies</p><p>genetic risk variants in LAMA1 and enrichment for risk variants in lean compared</p><p>to obese cases. PLoS Genetics, 8(5), e1002741.</p><p></p><p>Palmer, N. D., McDonough, C. W., Hicks, P. J., Roh, B. H., Wing, M. R., An, S. S., &</p><p>Talbert, M. E. (2012). A genome-wide association search for type 2 diabetes genes</p><p>in African Americans. PloS one, 7(1), e29202.</p><p></p><p>Prokopenko, I., Langenberg, C., Florez, J. C., Saxena, R., Soranzo, N., Thorleifsson,</p><p>G., & Potter, S. C. (2009). Variants in MTNR1B influence fasting glucose</p><p>levels. Nature Genetics, 41(1), 77-81.</p><p></p><p>Qi, L., van Dam, R. M., Meigs, J. B., Manson, J. E., Hunter, D., & Hu, F. B. (2006).</p><p>Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis</p><p>in large-scale casecontrol study and meta-analysis. Human Molecular</p><p>Genetics, 15(11), 1914-1920.</p><p></p><p>Qu, D., Liu, J., Lau, C. W., & Huang, Y. (2014). IL-6 in Diabetes and Cardiovascular</p><p>Complications. British Journal of Pharmacology, 171: 35953603.</p><p></p><p>Qi, L., Cornelis, M. C., Kraft, P., Stanya, K. J., Linda Kao, W. H., Pankow, J. S., &</p><p>Sun, Q. (2010). Genetic variants at 2q24 are associated with susceptibility to type</p><p>2 diabetes. Human Molecular Genetics, 19(13), 2706-2715.</p><p></p><p>Radha, Venkatesan, Sekar Kanthimathi, Ranjit Mohan Anjana, and Viswanathan</p><p>Mohan. (2016). Genetics of Gestational Diabetes Mellitus. JPMA. The Journal of</p><p>the Pakistan Medical Association 66(9): S1114.</p><p></p><p>Raghavan, S., Pachucki, M. C., Chang, Y., Porneala, B., Fox, C. S., Dupuis, J., &</p><p>Meigs, J. B. (2016). Incident type 2 diabetes risk is influenced by obesity and</p><p>diabetes in social contacts: a social network analysis. Journal of General Internal</p><p>Medicine, 31(10), 1127-1133.</p><p></p><p>Russell, J. W., & Zilliox, L. A. (2014). Diabetic neuropathies. Continuum: Lifelong</p><p>Learning in Neurology, 20(5 Peripheral Nervous System Disorders), 1226.</p><p></p><p>Romn-Pintos, L. M., Villegas-Rivera, G., Rodrguez-Carrizalez, A. D., Miranda-Daz,</p><p>A. G., & Cardona-Muoz, E. G. (2016). Diabetic polyneuropathy in type 2</p><p>diabetes mellitus: inflammation, oxidative stress, and mitochondrial</p><p>function. Journal of Diabetes Research, 2016.</p><p></p><p>Ranasinghe, P., Cooray, D. N., Jayawardena, R., & Katulanda, P. (2015). The influence</p><p>of family history of hypertension on disease prevalence and associated metabolic</p><p>risk factors among Sri Lankan adults. BMC Public Health, 15(1), 576.</p><p></p><p>Rao, P., Wang, H., Fang, H., Gao, Q., Zhang, J., Song, M., & Wang, W. (2016).</p><p>Association between IGF2BP2 polymorphisms and type 2 diabetes mellitus: a</p><p>casecontrol study and meta-analysis. International Journal of Environmental</p><p>Research and Public Health, 13(6), 574.</p><p></p><p>Rehman, K., & Akash, M. S. H. (2016). Mechanisms of inflammatory responses and</p><p>development of insulin resistance: how are they interlinked? Journal of Biomedical Science, 23(1), 87.</p><p></p><p>Riddy, D. M., Delerive, P., Summers, R. J., Sexton, P. M., & Langmead, C. J. (2018).</p><p>G proteincoupled receptors targeting insulin resistance, obesity, and type 2</p><p>diabetes mellitus. Pharmacological Reviews, 70(1), 39-67.</p><p></p><p>Rodrigues, K. F., Pietrani, N. T., Bosco, A. A., Campos, F. M. F., Sandrim, V. C., &</p><p>Gomes, K. B. (2017). IL-6, TNF-, and IL-10 levels/polymorphisms and their</p><p>association with type 2 diabetes mellitus and obesity in Brazilian</p><p>individuals. Archives of Endocrinology and Metabolism, 61(5), 438-446.</p><p></p><p>Rudofsky Jr, G., Schlotterer, A., Reismann, P., Engel, J., Grafe, I. A., Tafel, J., &</p><p>Hamann, A. (2009). The 174G> C IL-6 gene promoter polymorphism and</p><p>diabetic microvascular complications. Hormone and Metabolic Research, 41(04),</p><p>308-313.</p><p></p><p>Rosengren, A. H., Jokubka, R., Tojjar, D., Granhall, C., Hansson, O., Li, D. Q., &</p><p>Groop, L. (2010). Overexpression of alpha2A-adrenergic receptors contributes to</p><p>type 2 diabetes. Science, 327(5962), 217-220.</p><p></p><p>Rung, J., Cauchi, S., Albrechtsen, A., Shen, L., Rocheleau, G., Cavalcanti-Proena, C.,</p><p>& Charpentier, G. (2009). Genetic variant near IRS1 is associated with type 2</p><p>diabetes, insulin resistance and hyperinsulinemia. Nature Genetics, 41(10), 1110.</p><p></p><p>Sulaiman, M. K. (2019). Diabetic nephropathy: recent advances in pathophysiology and</p><p>challenges in dietary management. Diabetology & Metabolic Syndrome, 11(1), 7.</p><p></p><p>Salman, Ali Naeem. 2018. The Some Cytokines Levels (TGF1, IL-4 , IL-6, and IL-</p><p>17) in Sera Patients with Diabetes Mellitus Type1,Type 2 in Nassiriya City</p><p>1Rasha. Rasha Salih Nuhiar 6(4).</p><p></p><p>Sarvas, J. L., Khaper, N., & Lees, S. J. (2013). The IL-6 paradox: context dependent</p><p>interplay of SOCS3 and AMPK. Journal of Diabetes and Metabolism, 13(15).</p><p></p><p>Saxena, M., Srivastava, N., & Banerjee, M. (2013). Association of IL-6, TNF- and IL-</p><p>10 gene polymorphisms with type 2 diabetes mellitus. Molecular Biology</p><p>Reports, 40(11), 6271-6279.</p><p></p><p>Saxena, M., & Modi, D. R. (2014). Inflammation and diabetes. Interdisciplinary</p><p>Journal of Microinflammation, 1(110), 2.</p><p></p><p>Saxena, M., Agrawal, C. G., Srivastava, N., & Banerjee, M. (2014). Interleukin-6 (IL-</p><p>6)-597 A/G (rs1800797) &-174 G/C (rs1800795) gene polymorphisms in type 2</p><p>diabetes. The Indian Journal of Medical Research, 140(1), 60.</p><p></p><p>Sarkar, G., Cassady, J., Bottema, C. D., & Sommer, S. S. (1990). Characterization of</p><p>polymerase chain reaction amplification of specific alleles. Analytical</p><p>Biochemistry, 186(1), 64-68.</p><p></p><p>Shiau, M. Y., Lu, H. F., Chang, Y. H., Chiu, Y. C., & Shih, Y. L. (2015).</p><p>Characterization of proteins regulated by interleukin-4 in 3T3-L1</p><p>adipocytes. SpringerPlus, 4(1), 242.</p><p></p><p>Shih, Y. L., Ho, K. T., Tsao, C. H., Chang, Y. H., Shiau, M. Y., Huang, C. N., & Yang,</p><p>S. C. (2013). Role of cyotkines in metabolism and type 2 diabetes</p><p>mellitus. International Journal of Biomedical Laboratory Science, 2(1), 1-6.</p><p></p><p>Sindhughosa, D. A., & Pranamartha, A. G. M. K. (2017). The involvement of</p><p>proinflammatory cytokines in diabetic nephropathy: Focus on interleukin 1 (IL-</p><p>1), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-) signaling</p><p>mechanism. Bali Medical Journal, 6, 299.</p><p></p><p>Sorkin, D. H., Mavandadi, S., Rook, K. S., Biegler, K. A., Kilgore, D., Dow, E., & Ngo-</p><p>Metzger, Q. (2014). Dyadic collaboration in shared health behavior change: the</p><p>effects of a randomized trial to test a lifestyle intervention for high-risk</p><p>Latinas. Health Psychology, 33(6), 566.</p><p></p><p>Stanckov, A., & Laakso, M. (2016). Genetics of type 2 diabetes. In Novelties in</p><p>Diabetes 31, 203-220.</p><p></p><p>Steffen, B. T., Steffen, L. M., Zhou, X., Ouyang, P., Weir, N. L., & Tsai, M. Y. (2015).</p><p>n-3 Fatty acids attenuate the risk of diabetes associated with elevated serum</p><p>nonesterified fatty acids: the multi-ethnic study of atherosclerosis. Diabetes</p><p>Care, 38(4), 575-580.</p><p></p><p>Stephens, J. W., Hurel, S. J., Cooper, J. A., Acharya, J., Miller, G. J., & Humphries, S.</p><p>E. (2004). A common functional variant in the interleukin-6 gene is associated</p><p>with increased body mass index in subjects with type 2 diabetes</p><p>mellitus. Molecular Genetics and Metabolism, 82(2), 180-186.</p><p></p><p>Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., &</p><p>Lazar, M. A. (2001). The hormone resistin links obesity to</p><p>diabetes. Nature, 409(6818), 307.</p><p></p><p>Strawbridge, R. J., Dupuis, J., Prokopenko, I., Barker, A., Ahlqvist, E., Rybin, D., &</p><p>Nica, A. (2011). Genome-wide association identifies nine common variants</p><p>associated with fasting proinsulin levels and provides new insights into the</p><p>pathophysiology of type 2 diabetes. Diabetes, 60(10), 2624-2634.</p><p></p><p>Scott, R. A., Lagou, V., Welch, R. P., Wheeler, E., Montasser, M. E., Mgi, R., &</p><p>Rasmussen-Torvik, L. J. (2012). Large-scale association analyses identify new</p><p>loci influencing glycemic traits and provide insight into the underlying biological</p><p>pathways. Nature genetics, 44(9), 991-1005.</p><p></p><p>Saxena, R., Hivert, M. F., Langenberg, C., Tanaka, T., Pankow, J. S., Vollenweider, P.,</p><p>& Kao, W. L. (2010). Genetic variation in GIPR influences the glucose and insulin</p><p>responses to an oral glucose challenge. Nature Genetics, 42(2), 142-148.</p><p></p><p>Saxena, R., Elbers, C. C., Guo, Y., Peter, I., Gaunt, T. R., Mega, J. L., & Johnson, T.</p><p>(2012). Large-scale gene-centric meta-analysis across 39 studies identifies type 2</p><p>diabetes loci. The American Journal of Human Genetics, 90(3), 410-425.</p><p></p><p>Saxena, R., Saleheen, D., Been, L. F., Garavito, M. L., Braun, T., Bjonnes, A., & Sim,</p><p>X. (2013). Genome-wide association study identifies a novel locus contributing to</p><p>type 2 diabetes susceptibility in Sikhs of Punjabi origin from</p><p>India. Diabetes, 62(5), 1746-1755.</p><p></p><p>Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I., Chen, H., &</p><p>Hughes, T. E. (2007). Diabetes Genetics Initiative of Broad Institute of Harvard</p><p>and MIT, Lund University, and Novartis Institutes of BioMedical Research.</p><p>Genome-wide association analysis identifies loci for type 2 diabetes and</p><p>triglyceride levels. Science, 316(5829), 1331-1336.</p><p></p><p>Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., & Balkau, B. (2007).</p><p>A genome-wide association study identifies novel risk loci for type 2</p><p>diabetes. Nature, 445(7130), 881-885.</p><p></p><p>Shu, X. O., Long, J., Cai, Q., Qi, L., Xiang, Y. B., Cho, Y. S., & Go, M. J. (2010).</p><p>Identification of new genetic risk variants for type 2 diabetes. PLoS Genetics, 6(9),</p><p>e1001127.</p><p></p><p>Sandhu, M. S., Weedon, M. N., Fawcett, K. A., Wasson, J., Debenham, S. L., Daly, A.,</p><p>& Blech, I. (2007). Common variants in WFS1 confer risk of type 2</p><p>diabetes. Nature Genetics, 39(8), 951-953.</p><p></p><p>Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory</p><p>Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring, NY</p><p></p><p>Sim, X., Ong, R. T. H., Suo, C., Tay, W. T., Liu, J., Ng, D. P. K., & Teo, Y. Y. (2011).</p><p>Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from</p><p>Southeast Asia. PLoS Genetics, 7(4), e1001363.</p><p></p><p>Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T.,</p><p>Walters, G. B., & Baker, A. (2007). A variant in CDKAL1 influences insulin</p><p>response and risk of type 2 diabetes. Nature Genetics, 39(6), 770-775.</p><p></p><p>Talaei, A., Mohamadi, M., & Adgi, Z. (2013). The effect of vitamin D on insulin</p><p>resistance in patients with type 2 diabetes. Diabetology and Metabolic</p><p>Syndrome, 5(1), 8.</p><p></p><p>Tallapragada, D. S. P., Bhaskar, S., & CHANDAK, G. R. (2015). New insights from</p><p>monogenic diabetes for common type 2 diabetes. Frontiers in Genetics, 6, 251.</p><p></p><p>Tariq, Rehan, Khalid Idrees Khan, Rizwan Ali Masood, and Zafeer Naeem Wain. 2016.</p><p>Natural Remedies for Diabetes Mellitus. International Current Pharmaceutical</p><p>Journal Review 5(11): 97102.</p><p></p><p>Tolman, K. G., Fonseca, V., Dalpiaz, A., & Tan, M. H. (2007). Spectrum of liver</p><p>disease in type 2 diabetes and management of patients with diabetes and liver</p><p>disease. Diabetes Care, 30(3), 734-743.</p><p></p><p>Tsao, C. H., Shiau, M. Y., Chuang, P. H., Chang, Y. H., & Hwang, J. (2014).</p><p>Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting</p><p>lipolysis. Journal of Lipid Research, 55(3), 385-397.</p><p></p><p>Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014). Cytokines and</p><p>chemokines: at the crossroads of cell signalling and inflammatory</p><p>disease. Biochimica et Biophysica Acta (BBA)-Molecular Cell</p><p>Research, 1843(11), 2563-2582.</p><p></p><p>Testa, R., Olivieri, F., Bonfigli, A. R., Sirolla, C., Boemi, M., Marchegiani, F., &</p><p>Paolisso, G. (2006). Interleukin-6174 G> C polymorphism affects the association</p><p>between IL-6 plasma levels and insulin resistance in type 2 diabetic</p><p>patients. Diabetes Research and Clinical Practice, 71(3), 299-305.</p><p></p><p>Tsai, F. J., Yang, C. F., Chen, C. C., Chuang, L. M., Lu, C. H., Chang, C. T., & Chang,</p><p>C. C. (2010). A genome-wide association study identifies susceptibility variants</p><p>for type 2 diabetes in Han Chinese. PLoS Genet, 6(2), e1000847.</p><p></p><p>Thorleifsson, G., Walters, G. B., Gudbjartsson, D. F., Steinthorsdottir, V., Sulem, P.,</p><p>Helgadottir, A., & Jonsdottir, T. (2009). Genome-wide association yields new</p><p>sequence variants at seven loci that associate with measures of obesity. Nature</p><p>genetics, 41(1), 18-24.</p><p></p><p>Tabassum, R., Chauhan, G., Dwivedi, O. P., Mahajan, A., Jaiswal, A., Kaur, I., &</p><p>Chidambaram, M. (2013). Genome-wide association study for type 2 diabetes in</p><p>Indians identifies a new susceptibility locus at 2q21. Diabetes, 62(3), 977-986.</p><p></p><p>Underwood, P. C., Chamarthi, B., Williams, J. S., Sun, B., Vaidya, A., Raby, B. A., &</p><p>Williams, G. H. (2012). Replication and meta-analysis of the gene-environment</p><p>interaction between body mass index and the interleukin-6 promoter</p><p>polymorphism with higher insulin resistance. Metabolism, 61(5), 667-671.</p><p></p><p>Unnikrishnan, R., Pradeepa, R., Joshi, S. R., & Mohan, V. (2017). Type 2 diabetes:</p><p>demystifying the global epidemic. Diabetes, 66(6), 1432-1442.</p><p></p><p>Vana, D. R., Adapa, D., Prasad, V. S. S., Choudhury, A., & Ahuja, G. (2019). Diabetes</p><p>mellitus types: key genetic determinants and risk assessment. Genetics and</p><p>Molecular Research, 18(2).</p><p></p><p>Vornanen, M., Konttinen, H., Kriinen, H., Mnnist, S., Salomaa, V., Perola, M., &</p><p>Haukkala, A. (2016). Family history and perceived risk of diabetes, cardiovascular</p><p>disease, cancer, and depression. Preventive Medicine, 90, 177-183.</p><p></p><p>Votsi, C., Toufexis, C., Michailidou, K., Antoniades, A., Skordis, N., Karaolis, M., &</p><p>Christodoulou, K. (2017). Type 2 diabetes susceptibility in the Greek-Cypriot</p><p>population: replication of associations with TCF7L2, FTO, HHEX, SLC30A8 and</p><p>IGF2BP2 polymorphisms. Genes, 8(1), 16.</p><p></p><p>Vozarova, B., Fernndez-Real, J. M., Knowler, W. C., Gallart, L., Hanson, R. L.,</p><p>Gruber, J. D., & Wolford, J. K. (2003). The interleukin-6 ( 174) G/C promoter</p><p>polymorphism is associated with type-2 diabetes mellitus in Native Americans and</p><p>Caucasians. Human Genetics, 112(4), 409-413.</p><p></p><p>Vozarova, B., Weyer, C., Hanson, K., Tataranni, P. A., Bogardus, C., & Pratley, R. E.</p><p>(2001). Circulating interleukin-6 in relation to adiposity, insulin action, and insulin</p><p>secretion. Obesity Research, 9(7), 414-417.</p><p></p><p>Vidhate, D. A., Thomas, J., & Gupte, A. M. (2013). Association of IL-6 with diabetes</p><p>mellitus in Indian population from Navi Mumbai. International Journal of Recent</p><p>Trends in Science and Technology, 8(2), 100-102.</p><p></p><p>Vieira Ribeiro, F., de Mendona, A. C., Santos, V. R., Bastos, M. F., Figueiredo, L. C.,</p><p>& Duarte, P. M. (2011). Cytokines and bone-related factors in systemically healthy</p><p>patients with chronic periodontitis and patients with type 2 diabetes and chronic</p><p>periodontitis. Journal of Periodontology, 82(8), 1187-1196.</p><p></p><p>Voight, B. F., Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., &</p><p>McCulloch, L. J. (2010). Twelve type 2 diabetes susceptibility loci identified</p><p>through large-scale association analysis. Nature Genetics, 42(7), 579.</p><p></p><p>Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A.</p><p>W. (2003). Obesity is associated with macrophage accumulation in adipose</p><p>tissue. The Journal of Clinical Investigation, 112(12), 1796-1808.</p><p></p><p>Wang, G., Zhang, Q., Xu, N., Xu, K., Wang, J., He, W., & Yang, T. (2014).</p><p>Associations between two polymorphisms (FokI and BsmI) of vitamin D receptor</p><p>gene and type 1 diabetes mellitus in Asian population: a meta-analysis. PLoS</p><p>One, 9(3), e89325.</p><p></p><p>Wedrychowicz, A., Dziatkowiak, H., & Sztefko, K. (2004). Interleukin-6 (IL-6) and</p><p>IGF-IGFBP system in children and adolescents with type 1 diabetes</p><p>mellitus. Experimental and Clinical Endocrinology and Diabetes, 112(08), 435-</p><p>439.</p><p></p><p>Wei, H., Feng, G., Pei, W., Gang, W., & Yuelin, Z. (2017). Association between</p><p>interleukin-4 genetic polymorphisms and the risk of cerebral infarction in a</p><p>population of China. Biomedical Research, 28(21), 9198-9203.</p><p></p><p>Wu, Y. L., Ding, Y. P., Gao, J., Tanaka, Y., & Zhang, W. (2013). Risk factors and</p><p>primary prevention trials for type 1 diabetes. International Journal of Biological</p><p>Sciences, 9(7), 666.</p><p></p><p>Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014). Risk factors contributing to type 2</p><p>diabetes and recent advances in the treatment and prevention. International</p><p>Journal of Medical Sciences, 11(11), 1185.</p><p></p><p>Wu, D. Y., Ugozzoli, L., Pal, B. K., & Wallace, R. B. (1989). Allele-specific enzymatic</p><p>amplification of beta-globin genomic DNA for diagnosis of sickle cell</p><p>anemia. Proceedings of the National Academy of Sciences, 86(8), 2757-2760.</p><p></p><p>Wu, Y., Jing, R., Dong, Y., Kuang, Q., Li, Y., Huang, Z., & Li, M. (2017). Functional</p><p>annotation of sixty-five type-2 diabetes risk SNPs and its application in risk</p><p>prediction. Scientific Reports, 7, 43709.</p><p></p><p>Weedon, M. N., Schwarz, P. E., Horikawa, Y., Iwasaki, N., Illig, T., Holle, R., & Evans,</p><p>J. (2003). Meta-analysis and a large association study confirm a role for calpain-</p><p>10 variation in type 2 diabetes susceptibility. The American Journal of Human</p><p>Genetics, 73(5), 1208-1212.</p><p></p><p>Xia, C., Rao, X., & Zhong, J. (2017). Role of T lymphocytes in type 2 diabetes and</p><p>diabetes-associated inflammation. Journal of diabetes research, 2017.</p><p></p><p>Xiao, L. M., Yan, Y. X., Xie, C. J., Fan, W. H., Xuan, D. Y., Wang, C. X., & Zhang, J.</p><p>C. (2009). Association among interleukin-6 gene polymorphism, diabetes and</p><p>periodontitis in a Chinese population. Oral Diseases, 15(8), 547-553.</p><p></p><p>Yang, Q. H., Zhang, Y., Zhang, X. M., & Li, X. R. (2019). Prevalence of diabetic</p><p>retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic</p><p>retinopathy in Asian T2DM patients: a systematic review and Metaanalysis.</p><p>International Journal of Ophthalmology, 12(2), 302.</p><p></p><p>Yao, L., Tak, Y. G., Berman, B. P., & Farnham, P. J. (2014). Functional annotation of</p><p>colon cancer risk SNPs. Nature Communications, 5, 5114.</p><p></p><p>Yamauchi, T., Hara, K., Maeda, S., Yasuda, K., Takahashi, A., Horikoshi, M., & Ng,</p><p>D. P. (2010). A genome-wide association study in the Japanese population</p><p>identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4AC2CD4B.</p><p>Nature Genetics, 42(10), 864-868.</p><p></p><p>Zaccardi, F., O'Donovan, G., Webb, D. R., Yates, T., Kurl, S., Khunti, K., &</p><p>Laukkanen, J. A. (2015). Cardiorespiratory fitness and risk of type 2 diabetes</p><p>mellitus: A 23-year cohort study and a meta-analysis of prospective</p><p>studies. Atherosclerosis, 243(1), 131-137.</p><p></p><p>Zaharieva, E., Kamenov, Z., Velikova, T., Tsakova, A., El-Darawish, Y., & Okamura,</p><p>H. (2018). Interleukin-18 serum level is elevated in type 2 diabetes and latent</p><p>autoimmune diabetes. Endocrine Connections, 7(1), 179-185.</p><p></p><p>Zamorano, J., Rivas, M. D., & Perez, G. M. (2003). Interleukin-4: A multifunctional</p><p>cytokine. Inmunologia, 22, 215-24.</p><p></p><p>Zhang, C., Bao, W., Rong, Y., Yang, H., Bowers, K., Yeung, E., & Kiely, M. (2013).</p><p>Genetic variants and the risk of gestational diabetes mellitus: a systematic</p><p>review. Human Reproduction Update, 19(4), 376-390.</p><p></p><p>Zhang, X., Ma, L., Peng, F., Wu, Y., Chen, Y., Yu, L., & Zhang, C. (2011). The</p><p>endothelial dysfunction in patients with type 2 diabetes mellitus is associated with</p><p>IL-6 gene promoter polymorphism in Chinese population. Endocrine, 40(1), 124.</p><p></p>

Similar Items